全文获取类型
收费全文 | 2086篇 |
免费 | 113篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 172篇 |
妇产科学 | 26篇 |
基础医学 | 226篇 |
口腔科学 | 58篇 |
临床医学 | 260篇 |
内科学 | 493篇 |
皮肤病学 | 73篇 |
神经病学 | 73篇 |
特种医学 | 391篇 |
外科学 | 89篇 |
综合类 | 44篇 |
预防医学 | 109篇 |
眼科学 | 19篇 |
药学 | 130篇 |
2篇 | |
肿瘤学 | 108篇 |
出版年
2023年 | 5篇 |
2022年 | 7篇 |
2021年 | 13篇 |
2020年 | 14篇 |
2019年 | 15篇 |
2018年 | 31篇 |
2017年 | 22篇 |
2016年 | 22篇 |
2015年 | 39篇 |
2014年 | 48篇 |
2013年 | 75篇 |
2012年 | 36篇 |
2011年 | 42篇 |
2010年 | 89篇 |
2009年 | 85篇 |
2008年 | 51篇 |
2007年 | 90篇 |
2006年 | 56篇 |
2005年 | 55篇 |
2004年 | 30篇 |
2003年 | 22篇 |
2002年 | 30篇 |
2001年 | 41篇 |
2000年 | 34篇 |
1999年 | 32篇 |
1998年 | 128篇 |
1997年 | 157篇 |
1996年 | 132篇 |
1995年 | 109篇 |
1994年 | 114篇 |
1993年 | 98篇 |
1992年 | 34篇 |
1991年 | 35篇 |
1990年 | 38篇 |
1989年 | 55篇 |
1988年 | 48篇 |
1987年 | 42篇 |
1986年 | 51篇 |
1985年 | 47篇 |
1984年 | 28篇 |
1983年 | 16篇 |
1982年 | 27篇 |
1981年 | 32篇 |
1980年 | 26篇 |
1979年 | 4篇 |
1978年 | 8篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1975年 | 14篇 |
1966年 | 1篇 |
排序方式: 共有2274条查询结果,搜索用时 0 毫秒
61.
62.
63.
64.
65.
66.
67.
Kumar Santosh Yelamanchili Sowmya Seth Pankaj Bidlack Jean M. Pendyala Gurudutt Maggirwar Sanjay Chang Sulie L. 《Journal of neuroimmune pharmacology》2021,16(4):699-705
This guest commentary introduces “The Neuroimmune Pharmacology of SARS-CoV-2,” a special theme issue for The Journal of Neuroimmune Pharmacology led by the Society on NeuroImmune Pharmacology. The issue builds on the Society’s Virtual Workshop on COVID-19 held April 9, 2021.
Graphical abstractTop row from left: Drs. Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack; Bottom row from left: Drs. Gurudutt Pendyala, Sanjay Maggirwar, and Sulie L. Chang.
68.
de Haas M; Kerst JM; van der Schoot CE; Calafat J; Hack CE; Nuijens JH; Roos D; van Oers RH; von dem Borne AE 《Blood》1994,84(11):3885-3894
In four healthy volunteers, we analyzed in detail the immediate in vivo effects on circulating neutrophils of subcutaneous administration of 300 micrograms of granulocyte colony-stimulating factor (G-CSF). Neutrophil activation was assessed by measurement of degranulation. Mobilization of secretory vesicles was shown by a decrease in leukocyte alkaline phosphatase content of the circulating neutrophils. Furthermore, shortly postinjection, Fc gamma RIII was found to be upregulated from an intracellular pool that we identified by immunoelectron microscopy as secretory vesicles. Intravascular release of specific granules was shown by increased plasma levels of lactoferrin and by upregulation of the expression of CD66b and CD11b on circulating neutrophils. Moreover, measurement of fourfold elevated plasma levels of elastase, bound to its physiologic inhibitor alpha 1- antitrypsin, indicated mobilization of azurophil granules. However, no expression of CD63, a marker of azurophil granules, was observed on circulating neutrophils. G-CSF--induced mobilization of secretory vesicles and specific granules could be mimicked in whole blood cultures in vitro, in contrast to release of azurophil granules. Therefore, we postulate that the most activated neutrophils leave the circulation, as observed shortly postinjection, and undergo subsequent stimulation in the endothelial microenvironment, resulting in mobilization of azurophil granules. Our data demonstrate that G-CSF should be regarded as a potent immediate activator of neutrophils in vivo. 相似文献
69.
Irene Paganini Vivian Y Chang Gabriele L Capone Jeremie Vitte Matteo Benelli Lorenzo Barbetti Roberta Sestini Eva Trevisson Theo JM Hulsebos Marco Giovannini Stanley F Nelson Laura Papi 《European journal of human genetics : EJHG》2015,23(7):963-968
Schwannomatosis is characterized by the development of multiple non-vestibular, non-intradermal schwannomas. Constitutional inactivating variants in two genes, SMARCB1 and, very recently, LZTR1, have been reported. We performed exome sequencing of 13 schwannomatosis patients from 11 families without SMARCB1 deleterious variants. We identified four individuals with heterozygous loss-of-function variants in LZTR1. Sequencing of the germline of 60 additional patients identified 18 additional heterozygous variants in LZTR1. We identified LZTR1 variants in 43% and 30% of familial (three of the seven families) and sporadic patients, respectively. In addition, we tested LZTR1 protein immunostaining in 22 tumors from nine unrelated patients with and without LZTR1 deleterious variants. Tumors from individuals with LZTR1 variants lost the protein expression in at least a subset of tumor cells, consistent with a tumor suppressor mechanism. In conclusion, our study demonstrates that molecular analysis of LZTR1 may contribute to the molecular characterization of schwannomatosis patients, in addition to NF2 mutational analysis and the detection of chromosome 22 losses in tumor tissue. It will be especially useful in differentiating schwannomatosis from mosaic Neurofibromatosis type 2 (NF2). However, the role of LZTR1 in the pathogenesis of schwannomatosis needs further elucidation. 相似文献
70.
A significant proportion of hemophilia A patients receiving transfusions of factor VIII (FVIII) develop a specific antibody response towards FVIII. These antibodies are usually detected by assays in which they inhibit the function of the molecule, such as the Bethesda clotting test. We have prepared anti-FVIII antibodies by specific immunoadsorption from the plasma of four hemophiliacs with stable inhibitor levels. The isotypic distribution of such antibodies was determined and their capacity to bind to insolubilized FVIII was compared with their inhibitory activity in two functional assays, namely, the Bethesda assay and a chromogenic assay. In addition, the FVIII epitope specificity was determined by competition with monoclonal antibodies for the binding to insolubilized FVIII. We show here that (1) anti-FVIII antibodies are not isotypically restricted; thus, a significant proportion of specific IgG2 was found; (2) antibodies are frequently directed towards epitopes of FVIII that are not directly involved in the function of the molecule and therefore escape detection in the Bethesda method or chromogenic assay; and (3) each patient shows a unique pattern of FVIII epitope recognition. We conclude that evaluation of anti-FVIII antibodies by a functional method does not provide an accurate evaluation of the specific antibody response. These findings have important implications for the comparison of the immunogenicity of FVIII molecules produced by different technologies and for the development of methods to control anti-FVIII antibody production. 相似文献